SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-20-001625
Filing Date
2020-02-24
Accepted
2020-02-24 19:32:54
Documents
1
Period of Report
2020-02-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 20371
  Complete submission text file 0001562180-20-001625.txt   21766
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Fust Matthew K (Reporting) CIK: 0001397266 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36668 | Film No.: 20646697

Mailing Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025
Business Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025 650 421 7200
Dermira, Inc. (Issuer) CIK: 0001557883 (see all company filings)

IRS No.: 273267680 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations